Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2005European Journal of EndocrinologyOpen Access

Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFurio PaciniUniversity of Siena
Martin Schlumberger
Martin SchlumbergerUniversity of SienaCHClive HarmerNational Health Service

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pacini et al. (2005) studied this question.

synapsesocial.com/papers/6a9a415cf9da1bc1819e4ccehttps://doi.org/10.1530/eje.1.02014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma1998 · 373 citations
  2. 2Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients2001 · 85 citations
  3. 3Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer2001 · 1,362 citations
  4. 4Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice2004 · 113 citations